Back to 
Qube Research & Technologies Ltd
Qube Research & Technologies Ltd
CADL
Showing 0 of 4 quarters
Position history for Qube Research & Technologies Ltd's holdings in Candel Therapeutics, Inc.
No. Qube Research & Technologies exited its CADL (Candel Therapeutics) position in Q2 2024. Its Q1 2024 13F listed 1 shares worth $2. Qube Research & Technologies first reported CADL in Q3 2023 and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.